Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples
Launched by UNIVERSITY OF CALIFORNIA, IRVINE · Jan 29, 2014
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
The researcher can detect the defects in nervous system innervation to cutaneous blood vessels contribute to the pathogenesis of Port Wine Stain . Unveiling the pathogenic mechanisms of PWS is crucial to the design of new therapeutic strategies and can use the results to improve current PWS therapeutic outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female of all ages.
- • Not pregnant.
- • Has diagnosis of port wine stain on the arms, legs, chest, bac.
- • Ability to understand and carry out subject instructions.
- • Subject willing to have skin biopsies on port wine stain and normal skin areas.
- Exclusion Criteria:
- • Pregnant women.
- • Port Wine Stain on the face.
- • History of skin cancer.
- • Current participation in an investigational drug evaluation
- • Concurrent use of known photosensitizing drugs.
About University Of California, Irvine
The University of California, Irvine (UCI) is a leading research institution renowned for its commitment to advancing health and medical knowledge through innovative clinical trials. With a robust infrastructure for clinical research, UCI fosters interdisciplinary collaboration among its esteemed faculty and researchers, aiming to translate scientific discoveries into effective therapeutic solutions. The university prioritizes ethical standards and participant safety while addressing critical healthcare challenges across various fields, including cancer, neurology, and public health. UCI's dedication to excellence in research and education positions it as a pivotal contributor to the advancement of clinical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irvine, California, United States
Patients applied
Trial Officials
John s Nelson, MD
Study Director
Beckman Laser Institute, UCI
Winbin Tan, PhD
Principal Investigator
Beckman Laser Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials